Free Trial

Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics logo
$1.58 +0.02 (+0.96%)
As of 03:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BJDX vs. NURO, CODX, LFWD, TNON, SINT, POAI, LUCY, STRR, ICU, and STSS

Should you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include NeuroMetrix (NURO), Co-Diagnostics (CODX), Lifeward (LFWD), Tenon Medical (TNON), Sintx Technologies (SINT), Predictive Oncology (POAI), Innovative Eyewear (LUCY), Star Equity (STRR), SeaStar Medical (ICU), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

Bluejay Diagnostics vs. Its Competitors

NeuroMetrix (NASDAQ:NURO) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

19.4% of NeuroMetrix shares are owned by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are owned by institutional investors. 7.3% of NeuroMetrix shares are owned by insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

NeuroMetrix has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.

Bluejay Diagnostics has a net margin of 0.00% compared to NeuroMetrix's net margin of -203.71%. NeuroMetrix's return on equity of -42.56% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroMetrix-203.71% -42.56% -39.26%
Bluejay Diagnostics N/A -322.46%-262.96%

In the previous week, NeuroMetrix's average media sentiment score of 0.00 equaled Bluejay Diagnostics'average media sentiment score.

Company Overall Sentiment
NeuroMetrix Neutral
Bluejay Diagnostics Neutral

NeuroMetrix has higher revenue and earnings than Bluejay Diagnostics. NeuroMetrix is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroMetrix$3.03M3.09-$6.53M-$4.59-0.99
Bluejay Diagnostics$250K9.39-$7.72M-$379.740.00

Summary

NeuroMetrix beats Bluejay Diagnostics on 8 of the 11 factors compared between the two stocks.

Get Bluejay Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BJDX vs. The Competition

MetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.35M$6.76B$5.56B$9.41B
Dividend YieldN/A1.32%4.00%4.03%
P/E Ratio0.0025.7628.3619.88
Price / Sales9.3995.06443.6399.98
Price / CashN/A20.4724.9928.17
Price / Book0.154.658.285.72
Net Income-$7.72M$176.14M$3.23B$257.57M
7 Day Performance-3.96%2.65%3.82%3.74%
1 Month Performance0.96%4.03%9.69%14.06%
1 Year Performance-94.99%6.35%34.31%17.27%

Bluejay Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BJDX
Bluejay Diagnostics
0.4939 of 5 stars
$1.58
+1.0%
N/A-95.0%$2.35M$250K0.009Positive News
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+19.8%$9.37M$3.03M-0.9920High Trading Volume
CODX
Co-Diagnostics
3.7942 of 5 stars
$0.27
+6.1%
$5.50
+1,973.9%
-77.7%$8.90M$3.91M-0.23100High Trading Volume
LFWD
Lifeward
1.959 of 5 stars
$0.75
+2.9%
$9.00
+1,100.0%
-80.6%$8.26M$25.66M-0.2560
TNON
Tenon Medical
1.536 of 5 stars
$1.03
+1.0%
$4.67
+353.1%
+75.1%$7.82M$3.28M-0.048
SINT
Sintx Technologies
2.9638 of 5 stars
$2.97
-10.8%
$28.00
+842.8%
-45.5%$7.46M$2.89M-0.0640Positive News
Gap Down
High Trading Volume
POAI
Predictive Oncology
2.701 of 5 stars
$0.80
+1.3%
$3.00
+275.0%
-28.0%$7.14M$1.62M-0.2630
LUCY
Innovative Eyewear
0.1149 of 5 stars
$2.15
+1.4%
N/A-60.5%$6.66M$1.71M-0.549News Coverage
Gap Up
STRR
Star Equity
3.5168 of 5 stars
$1.96
-2.0%
$5.00
+155.1%
-55.8%$6.29M$57.17M-0.57460Positive News
ICU
SeaStar Medical
0.5616 of 5 stars
$0.56
-5.3%
N/A-90.8%$6.27M$428K-0.162
STSS
Sharps Technology
0.865 of 5 stars
$5.87
+2.4%
N/AN/A$5.98MN/A0.003

Related Companies and Tools


This page (NASDAQ:BJDX) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners